L3Harris Technologies Q2 2026: Revenue and Margins Rise

L3Harris Technologies (LHX) reported second-quarter 2026 results that show revenue growth, operating margin expansion, and accelerating balance sheet deleveraging occurring simultaneously — a combination that defines the company's current mid-cycle expansion phase. The 10-Q for the period ending July 3, 2026, filed on July 30, 2026, documents an 8.4% year-over-year revenue increase alongside a 31% jump in net income, driven in part by falling interest expense on a rapidly shrinking debt load. Every major financial metric in the filing moved in the same direction at once.

The Headline Numbers

Revenue for the quarter ending July 3, 2026, reached $5.88 billion, up from $5.43 billion in the comparable period ending June 27, 2025 — an 8.4% year-over-year increase. For a large-cap defense prime, that rate of top-line growth is notably above the low-to-mid single-digit historical norm for the sector, pointing to a demand environment that is meaningfully favorable.

Operating income climbed from $571 million to $654 million, a 14.5% increase. The fact that operating income grew faster than revenue signals genuine margin expansion rather than simple volume growth. Net income moved faster still, rising 31% from $458 million to $600 million. Earnings per share increased from $2.44 to $3.13, a 28.3% gain. The divergence between operating income growth of 14.5% and net income growth of 31% points to a below-the-line tailwind — almost certainly reduced interest expense flowing from the debt reduction detailed in the balance sheet section below.

What Changed: Margins, Mix, and the Limits of the Available Excerpt

The operating leverage on display — operating income expanding at roughly 1.7 times the rate of revenue — confirms that the LHX portfolio as a whole is becoming more profitable, even if the filing excerpt does not provide a segment-level breakdown to identify exactly where the improvement is concentrated. The company operates across multiple business segments, and the filing references internal "realignments" from the first quarter of 2026 that were assessed for impairment. The filing is explicit that those assessments "indicated no impairment existed either before or after the realignments," clearing the impairment test cleanly. The specific nature of the realignments is not characterized in the available filing text.

On the accounting and controls front, management's disclosures are unambiguously clean. The CEO and CFO certified that "as of July 3, 2026, our disclosure controls and procedures were designed at a reasonable assurance level and were effective." The filing also states there were "no new accounting pronouncements that became effective during second quarter 2026 that have had a material impact" on the financial statements, and that there were "no changes in our internal control over financial reporting during second quarter 2026 that have materially affected, or are reasonably likely to materially affect" those controls. No restatement risk and no control weaknesses are flagged anywhere in the filing.

Critically, the filing does not disclose any fixed-price contract charges or cost-overrun losses for the quarter. Defense primes carry material exposure to development-stage fixed-price programs, where cost overruns are absorbed by the contractor rather than the customer. The absence of any such charge this quarter is a meaningful positive data point, even if it does not eliminate the risk going forward.

Balance Sheet and Liquidity: A Structural Shift

The balance sheet transformation is the most striking element of the Q2 2026 filing. Long-term debt fell 16.3% year-over-year, from $10.98 billion to $9.18 billion — approximately $1.8 billion of debt retired in twelve months. LHX carried that elevated debt load largely as a legacy of its 2019 merger with Harris Corporation and subsequent portfolio activity. Defense primes typically target debt-to-EBITDA ratios in the two-to-three-times range; at nearly $11 billion, LHX had been running above that comfort zone. The move toward $9.18 billion represents meaningful progress toward normalization.

At the same time, cash and equivalents surged 215.6% year-over-year, from $482 million to $1.52 billion. A year ago, the company held less than half a billion in cash against nearly $11 billion in long-term debt. As of July 3, 2026, it holds $1.52 billion against $9.18 billion. When debt reduction and cash accumulation are combined, the net debt position improved by roughly $3 billion over twelve months — a high-velocity deleveraging pace by any standard. The filing's market risk section confirms this is an active management priority, noting the long-term debt repayment as the primary driver of any change in the company's market risk profile, and stating explicitly there were "no material changes during second quarter 2026 with respect to our exposure to market risk" beyond that debt activity.

The cash build provides LHX with meaningfully greater operational flexibility to absorb program timing mismatches, fund capital expenditures, and continue debt service without financial stress. The filing excerpt does not provide specific lease obligation detail or flag material off-balance-sheet exposures in the sections available, and the market risk commentary implies no new material lease or derivative exposures were introduced during the quarter.

Risks and Disclosures

The filing does not identify any new or materially escalated risk factors relative to prior filings. For a defense prime, the standard risk universe includes continuing resolution environments that block new program starts by funding the government at prior-year levels, foreign military sales timing variability, fixed-price contract exposure, and supply chain constraints. None of those risks appear to have been elevated in language or newly introduced in this quarter's filing.

The forward-looking concern most worth monitoring is the fixed-price development contract category. As noted above, the filing discloses no charges in this area for Q2 2026, which is a confirmation rather than a red flag. However, a single large fixed-price charge in a future quarter can erase multiple quarters of margin progress, making it a category that warrants ongoing scrutiny in any analysis of LHX or its defense prime peers. The filing provides no basis to elevate concern here today, but it does not eliminate the structural risk either.

A second monitoring point is funded backlog, which is not present in the available filing excerpt. Funded backlog is the primary leading indicator for a defense prime's revenue visibility. The filing does not provide that figure in the sections reviewed, and no estimate will be substituted here. Investors should seek that data point in the full earnings release accompanying the filing.

What to Watch

Three metrics will determine whether the financial trajectory documented in this filing continues. First, the pace of long-term debt reduction: whether LHX advances toward the $8 billion range or plateaus at current levels will directly affect the interest expense tailwind that has been amplifying net income growth beyond operating income growth. Second, free cash flow conversion: defense earnings are accrual-heavy, and the cash balance build seen here is encouraging, but confirming that net income is converting to actual free cash flow — rather than reflecting working capital timing — requires review of the full cash flow statement. Third, book-to-bill ratio: a ratio above 1.0 signals that orders are outpacing deliveries and the funded backlog is growing, sustaining the revenue trajectory; a ratio below 1.0 would represent a contraction signal. That figure is not present in the available filing excerpt and should be tracked in LHX's full earnings release and subsequent investor communications.